382
Participants
Start Date
July 1, 2021
Primary Completion Date
December 2, 2022
Study Completion Date
December 2, 2022
Direct oral penicillin challenge
The patient will receive a single dose of oral penicillin, following baseline vital signs.
Standard of care
Routine management as per the treating clinicians that include skin prick and intradermal beta-lactam testing, followed by oral penicillin challenge in the setting of negative skin testing.
Peter MacCallum Cancer Center, Melbourne
Royal Melbourne Hospital, Melbourne
Austin Health, Heidelberg
Duke University Medical Center, Durham
Vanderbilt University Medical Center, Nashville
McGill University Health Centre (MUHC), Montreal
Lead Sponsor
Austin Health
OTHER_GOV